GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Net Margin %

Schott Pharma AG KGaA (WBO:1SXP) Net Margin % : 12.57% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Schott Pharma AG KGaA's Net Income for the three months ended in Dec. 2024 was €28.9 Mil. Schott Pharma AG KGaA's Revenue for the three months ended in Dec. 2024 was €229.8 Mil. Therefore, Schott Pharma AG KGaA's net margin for the quarter that ended in Dec. 2024 was 12.57%.

The historical rank and industry rank for Schott Pharma AG KGaA's Net Margin % or its related term are showing as below:

WBO:1SXP' s Net Margin % Range Over the Past 10 Years
Min: 13.26   Med: 15.53   Max: 16.9
Current: 14.05


WBO:1SXP's Net Margin % is ranked better than
80.73% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -0.76 vs WBO:1SXP: 14.05

Schott Pharma AG KGaA Net Margin % Historical Data

The historical data trend for Schott Pharma AG KGaA's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Net Margin % Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Net Margin %
13.26 15.53 15.27 16.90 15.64

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.12 10.69 18.24 14.33 12.57

Competitive Comparison of Schott Pharma AG KGaA's Net Margin %

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Schott Pharma AG KGaA's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Net Margin % distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's Net Margin % falls into.



Schott Pharma AG KGaA Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Schott Pharma AG KGaA's Net Margin for the fiscal year that ended in Sep. 2024 is calculated as

Net Margin=Net Income (A: Sep. 2024 )/Revenue (A: Sep. 2024 )
=149.685/957.091
=15.64 %

Schott Pharma AG KGaA's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=28.894/229.841
=12.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schott Pharma AG KGaA  (WBO:1SXP) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Schott Pharma AG KGaA Net Margin % Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines